ENBIO Co., Ltd. (KOSDAQ:352940)
2,670.00
-30.00 (-1.11%)
Last updated: Jun 26, 2025
ENBIO Revenue
ENBIO had revenue of 13.83B KRW in the quarter ending March 31, 2025, a decrease of -11.41%. This brings the company's revenue in the last twelve months to 33.87B, up 15.14% year-over-year. In the year 2024, ENBIO had annual revenue of 35.65B with 4.79% growth.
Revenue (ttm)
33.87B
Revenue Growth
+15.14%
P/S Ratio
0.86
Revenue / Employee
423.42M
Employees
80
Market Cap
29.13B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 35.65B | 1.63B | 4.79% |
Dec 31, 2023 | 34.02B | -215.53M | -0.63% |
Dec 31, 2022 | 34.24B | 773.80M | 2.31% |
Dec 31, 2021 | 33.47B | -1.10B | -3.17% |
Dec 31, 2020 | 34.56B | 827.52M | 2.45% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.10T |
SK hynix | 71.40T |
Samsung Biologics | 4,898.69B |
LG Energy Solution | 25.76T |
Hyundai Motor Company | 178.98T |
Doosan Enerbility | 15.88T |
Hanwha Aerospace | 15.28T |
KB Financial Group | 14.93T |